Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.400
-0.140 (-9.09%)
At close: Nov 20, 2024, 4:00 PM
1.470
+0.070 (5.00%)
After-hours: Nov 20, 2024, 4:24 PM EST

Evaxion Biotech Revenue

Evaxion Biotech had revenue of $3.02M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $3.30M. In the year 2023, Evaxion Biotech had annual revenue of $73.00K.

Revenue (ttm)
$3.30M
Revenue Growth
n/a
P/S Ratio
1.96
Revenue / Employee
$67,245
Employees
49
Market Cap
7.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202373.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Precipio 17.41M
Mobile-health Network Solutions 13.97M
Jaguar Health 10.48M
Evogene 9.45M
Ensysce Biosciences 4.42M
RedHill Biopharma 3.71M
BioRestorative Therapies 377.00K
Soligenix 364.18K
Revenue Rankings